Gaurab’s research, teaching, and consulting expertise are in strategy, innovation, entrepreneurship, and decision making in science-based companies, especially those in biotechnology, pharmaceuticals, medical devices and diagnostics, agriculture, healthcare, and chemicals.  He has also consulted in financial services. 

In his executive education and consulting work, Gaurab has worked with managers, scientists, and other professionals from Biogen Idec, Dana Farber Cancer Institute, Eli Lilly, EMC, Lucent, Massachusetts Biotechnology Council, Novartis, Vertex Pharmaceuticals, and others. 

Gaurab is the faculty director of Babson’s executive education program “Bio-Pharma: Mastering the Business of Science” for biotechnology and pharmaceuticals scientists and managers.  In addition to teaching competition and strategy in this program, he teaches in the Evening MBA program for working professionals.

The National Science Foundation and the Eleutherian Mills – Hagley Foundation have funded his on-going research program on the “Management of Distant Returns” where he is investigating how people make complex decisions that are highly uncertain and ambiguous, and whose outcomes take shape over many years.  His research, writing, and professional presentations are on discovery processes of corporate scientists, science and strategy for achieving long-term corporate growth, anticipatory innovation and entrepreneurship, and effective decision making. 

Gaurab’s research has been published in the journals Management Science, Expert Opinion on Drug Discovery, Chemical Heritage, and as a chapter in the book Innovating Strategy Process.  He has written for BioExecutive International and Babson Insight and his work has been covered in Effective Executive.